More than two dozen lawsuits have been filed by patients who allege that they suffered from dizziness, electrical sensations in the brain and other side effects after they stopped taking the prescription drug Cymbalta.
The suits, filed in 15 states, claim that Eli Lilly & Co., which makes Cymbalta, failed to warn its customers about the withdrawal side effects, which also include nausea, vomiting, sweating, insomnia, nightmares and diarrhea. On Aug. 15, plaintiffs attorneys moved to coordinate 27 lawsuits for pretrial purposes and said there could be “many hundreds, if not thousands, of cases.” Lilly’s response is due Sept. 9.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
